A cancer researcher tampered with data and fudged images in a presentation and grant application, the linkurl:Office of Research Integrity (ORI);http://ori.dhhs.gov/misconduct/cases/Ningaraj_Nagendra.shtml reported.
According to ORI's notice released this Fall, linkurl:Nagendra Ningaraj,;http://www.memorialhealth.com/aci/research/ningaraj.aspx formerly an associate professor of neurological surgery and cancer biology at Vanderbilt University School of Medicine, switched images of control and experimentally treated brain tumors and presented data from older experiments as new findings. The data were included in a presentation during the American Association for Cancer Research meeting in 2005 and in a grant to the National Institutes of Health. Ningaraj's research focused on new approaches to treat brain tumors using an agonist to help a drug traverse the normal blood-brain barrier and reach the tumor. A spokesperson from ORI told The Scientist in an email that the misconduct was first uncovered when one of Ningaraj's coauthors and colleagues noticed something unusual in the...
 |
Image: Wikimedia |
Cancer Biology & Therapy,BMC Cancer,European Journal of Pharmacology,Expert Opinion on Drug Delivery.Correction (posted December 23): It has come to our attention that the misconduct was limited to 1 grant application and 1 presentation. As a result, we have corrected the story from its original version.
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
